A Pilot Study Using Autologous Regulatory T Cell Infusion Zortress (Everolimus) in Renal Transplant Recipients

NCT03284242 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

End Stage Renal Disease
Kidney Transplant

Interventions

DRUG: Treg

Sponsor

Roberto Gedaly

Collaborators

[object Object]